GMO Financial Gate (4051) Q3 2026 earnings summary

Executive summary

• Recurring-model revenue grew 26.7% year-over-year, driven by full-scale activation of the cashless platform at major commercial facilities and drugstores, as well as strong contributions from large commercial facilities and life necessities merchants.

• Revenue for the nine months ended June 30, 2026, rose 22.6% year-over-year to ¥16.17bn, with operating profit up 23.6% to ¥2.23bn and profit attributable to owners at ¥1.50bn (+11.2% YoY).

• Active IDs rose to 482K (+13.7% YoY), with transaction volume up 34.4% YoY and ARPU up 12.8% YoY.

• Ecosystem expansion and enterprise client initiatives are advancing, targeting 1mn active IDs by FY2033.

Financial highlights

• Recurring-model revenue: ¥8.14bn (+26.7% YoY), now 50.4% of total revenue.

• Gross profit for Q3 FY2026 was ¥5.63bn (+13.4% YoY), with operating profit at ¥2.24bn (+23.6% YoY).

• Basic earnings per share increased to ¥182.03 from ¥163.48 year-over-year.

• Total assets as of June 30, 2026, were ¥17.18bn, up from ¥13.83bn at the end of FY2025.

• Cash and cash equivalents increased to ¥5.14bn from ¥4.26bn at the end of FY2025.

Outlook and guidance

• Tracking ahead of plan for FY2026 operating profit of ¥2.8bn and FY2033 target of ¥10bn.

• Full-year FY2026 revenue is forecast at ¥19.73bn (up 10.1% YoY), with operating profit of ¥2.8bn (up 25.5% YoY) and profit attributable to owners of parent of ¥1.87bn (up 14.6% YoY).

• Focus on expanding active IDs, ARPU, and recurring gross profit margin to achieve long-term growth.

• Pipeline centered on high-activity merchants and life necessities domain, aiming for 1mn+ IDs by FY2033.

• No change to previously released financial forecasts.